Leticia B. A. Rangel, Pharm.D., Ph.D., is an Associate Professor of the Department of Pharmaceutical Sciences and a member of the Biotechnology Program at the Federal University of Espirito Santo (UFES). As the head of the Laboratory of Cellular and Molecular Biology of Human Cancer, coordinates projects on ovarian cancer, breast, lung and kidney, with emphasis on the cellular and molecular mechanisms of these diseases, the development of biotechnology products and processes, and the discovery of new anticancer molecules. Her scientific network includes the Department of Chemistry (UFES), the Institute of Biophysics Carlos Chagas Filho (Federal University of Rio de Janeiro), the Division of Clinical Research of the Brazilian National Cancer Institute, The Department. of Molecular Medicine, University of Texas at San Antonio (USA), and the Department of Pathology at the Johns Hopkins University (USA), as well as the private sector. Aside from papers published on international journals, and ongoing patents negotiations, she has been awarded by the Brazilian government in recognition to her contribution in cancer research.